[1] |
JIANG Chaoyang , WANG Juan , ZHANG Ling , GAO Hui , ZHANG Tao , LI Zhihui .
Correlation analysis of neck node levels in 709 cases of nasopharyngeal carcinoma
[J]. China Oncology, 2021, 31(7): 629-634.
|
[2] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[3] |
LU Dasong, FENG Yongjun, WANG Wufeng, MOU Zhonglin, ZHAO Na .
Influence of individualized nutrition intervention on quality of life and survival prognosis of patients with locally advanced nasopharyngeal carcinoma
[J]. China Oncology, 2021, 31(12): 1202-1208.
|
[4] |
CHEN Gang, ZHANG Shunkang, SHEN Lei, SUN Liyun, ZHAO Yingwei, WANG Xin, WANG Huanhuan, LU Yue.
Comparison of three types of intensity-modulated radiotherapy plans for adjuvant whole breast and simultaneous tumor bed boost radiotherapy
[J]. China Oncology, 2020, 30(8): 611-619.
|
[5] |
SHI Zhiqiang , QIU Pengfei , LIU Yanbing , ZHAO Tong , SUN Xiao , CHEN Peng , WANG Chunjian , ZHANG Zhaopeng , CONG Binbin , WANG Yongsheng .
Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer
[J]. China Oncology, 2020, 30(3): 186-191.
|
[6] |
CHEN Xiaohui, WANG Jiazhou, HU Weigang, PENG Jiayuan, ZHAI Peng.
Dosimetric impact of machine and treatment planning system on knowledge-based planning: a study based on cervical cancer IMRT plan
[J]. China Oncology, 2020, 30(10): 821-825.
|
[7] |
ZHANG Qi, GUO Rong, LI Lun, XIU Bingqiu, YANG Benlong, WANG Jia, JI Weiru, SHAO Zhimin, WU Jiong.
Current status of adjuvant therapy for early stage breast cancer in China: a cross-sectional study based on 110 hospitals
[J]. China Oncology, 2019, 29(8): 561-567.
|
[8] |
YANG Qing, OU Xiaomin, HU Chaosu.
Prognostic significance of platelet-to-lymphocyte ratio in patients with nasopharyngeal carcinoma: a Meta-analysis
[J]. China Oncology, 2019, 29(8): 576-582.
|
[9] |
ZHENG Weizhen, SUN Jujie, LIU Yanbing, QIU Pengfei, BI Zhao, ZHAO Tong, WANG Yongsheng.
Validation and modification study of axillary node pathologic complete response predictive model after neoadjuvant chemotherapy for breast cancer
[J]. China Oncology, 2019, 29(6): 445-451.
|
[10] |
ZHANG Haiying, CHEN Yuanhua, ZHU Ji, LI Guichao, HU Weigang, PENG Jiayuan.
A feasibility study of quick auto-planning for rectal cancer radiotherapy
[J]. China Oncology, 2019, 29(4): 294-299.
|
[11] |
LI Wencheng, WANG Xiaoshen.
The selection and application of platinum drugs in the treatment of head and neck squamous cell carcinomas
[J]. China Oncology, 2019, 29(4): 300-306.
|
[12] |
WANG Yujie, Lü Tao, WANG Xiaoshen.
Effects of Notch1 knockout by CRISPR-Cas9 on the proliferation and radiosensitivity of CNE2 cell line
[J]. China Oncology, 2019, 29(2): 111-118.
|
[13] |
BI Zhao, LIU Jingjing, CHEN Peng, LIU Yanbing, ZHAO Tong, SUN Xiao, QIU Pengfei, WANG Yongsheng.
Internal mammary sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy
[J]. China Oncology, 2019, 29(2): 131-135.
|
[14] |
SUN Jiajun, LU Renquan, ZHENG Hui, et al.
The value of serum HER2-ECD level in neoadjuvant chemotherapy for breast cancer
[J]. China Oncology, 2019, 29(1): 32-36.
|
[15] |
HUANG Juan, CHEN Xiaohui, ZHAI Ruiping, et al.
A dosimetric study on the feasibility of using the anterior head and neck lymphatic drainage protection area for nasopharyngeal carcinoma intensity-modulated radiotherapy
[J]. China Oncology, 2018, 28(9): 692-697.
|